Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | DRD2 | P14416 | 1/20 | 0.35 |
| ▸ | DRD1 | P21728 | 1/20 | 0.35 |
| ▸ | DRD4 | P21917 | 1/20 | 0.35 |
| ▸ | DRD5 | P21918 | 1/20 | 0.35 |
| ▸ | DRD3 | P35462 | 1/20 | 0.35 |
| ▸ | CXCR2 | P25025 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7597785 | 0.85 | KMT2A (0.37) | HSD11B1ALDH1A1DRD2DRD1DRD4 | |
| SCHEMBL29414132 | 0.80 | TDP1 (0.44) | HSD11B1ALDH1A1TSHRTDP1DRD2 | |
| SCHEMBL1997201 | 0.80 | TDP1 (0.44) | HSD11B1ALDH1A1TSHRTDP1DRD2 | |
| Hydrogen Sulfide SCHEMBL4225727 | 0.79 | TDP1 (0.43) | HSD11B1ALDH1A1TSHRTDP1DRD2 | |
| Iodide SCHEMBL6927596 | 0.79 | TDP1 (0.43) | HSD11B1ALDH1A1TSHRTDP1DRD2 | |
| SCHEMBL2454892 | 0.79 | ALDH1A1 (0.47) | CA2ALDH1A1TSHRTDP1 | |
| Iodide SCHEMBL1286189 | 0.78 | DRD2 (0.37) | HSD11B1TDP1DRD2DRD1DRD4 | |
| SCHEMBL29678667 | 0.77 | DRD2 (0.36) | DRD2DRD1DRD4DRD5DRD3 | |
| SCHEMBL1637318 | 0.77 | RXRA (0.46) | TDP1DRD2DRD4DRD3 | |
| SCHEMBL12646954 | 0.77 | DRD2 (0.39) | ALDH1A1DRD2DRD1DRD4DRD5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101646648-B | Tert-butylphenyl sulfonate compound, nonaqueous electrolyte solution for lithium secondary battery using same, and lithium secondary battery using same | UBE IND JP | 2014-07-16 | — | — | CN | disclosed |
| US-20140011097-A1 | TERT-BUTYLPHENYL SULFONATE COMPOUND, NONAQUEOUS ELECTROLYTE SOLUTION FOR LITHIUM SECONDARY BATTERY USING THE SAME, AND LITHIUM SECONDARY BATTERY USING THE SAME | UBE INDUSTRIES, LTD. (JP) | 2014-01-09 | — | — | US | disclosed |
| US-8546599-B2 | Tert-butylphenyl sulfonate compound, nonaqueous electrolyte solution for lithium secondary battery using the same, and lithium secondary battery using the same | UBE INDUSTRIES, LTD. (JP) | 2013-10-01 | — | — | US | disclosed |
| CN-101795998-B | Method for producing aromatic compound | UBE INDUSTRIES | 2013-04-10 | — | — | CN | disclosed |
| US-8283508-B2 | Method for producing aromatic compound | UBE INDUSTRIES, LTD. (JP) | 2012-10-09 | — | — | US | disclosed |
| US-20110230694-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND | UBE INDUSTRIES, LTD. (JP) | 2011-09-22 | — | — | US | disclosed |
| CN-101795998-A | Method for producing aromatic compound | UBE INDUSTRIES | 2010-08-04 | — | — | CN | disclosed |
| US-20100055576-A1 | tert-BUTYLPHENYL SULFONATE COMPOUND, NONAQUEOUS ELECTROLYTE SOLUTION FOR LITHIUM SECONDARY BATTERY USING THE SAME, AND LITHIUM SECONDARY BATTERY USING THE SAME | MU IONIC SOLUTIONS CORPORATION (JP) | 2010-03-04 | — | — | US | disclosed |
| CN-101646648-A | Tert-butylphenyl sulfonate compound, nonaqueous electrolyte solution for lithium secondary battery using same, and lithium secondary battery using same | UBE IND JP | 2010-02-10 | — | — | CN | disclosed |
| EP-2133327-A1 | tert-BUTYLPHENYL SULFONATE COMPOUND, NONAQUEOUS ELECTROLYTE SOLUTION FOR LITHIUM SECONDARY BATTERY USING THE SAME, AND LITHIUM SECONDARY BATTERY USING THE SAME | Ube Industries, Ltd. (JP) | 2009-12-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100055576-A1 | tert-BUTYLPHENYL SULFONATE COMPOUND, NONAQUEOUS ELECTROLYTE SOLUTION FOR LITHIUM SECONDARY BATTERY USING THE SAME, AND LITHIUM SECONDARY BATTERY USING THE SAME | TERT, TST, TES | HSD11B1 2744/4885CA2 2362/4885ALDH1A1 4091/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.